How to use Technologies searched
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.
Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.
Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Novozymes is seeking technology opportunities
Novozymes is the biotech-based world leader in enzymes and microorganisms. Using nature's own technologies, they continuously expand the frontiers of biological solutions to improve industrial performance in all areas. With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world.
Technologies that can be made available through partnerships include:
- gene discovery, cloning, and sequencing
- expression profiling and DNA arraying
- low allergenic technologies
- man-made diversity of genes
- high-throughput screening of protein functionality
- gene expression in gene libraries and for production of gene products or metabolites.
They welcome technology opportunities in other areas which complement or act synergistically with theirs, since radical new solutions are often found by combining technologies.
To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login
Please click here to log in to view the complete profile.